Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002956577 | SCV003691082 | uncertain significance | Inborn genetic diseases | 2022-10-25 | criteria provided, single submitter | clinical testing | The c.3091C>T (p.R1031C) alteration is located in exon 22 (coding exon 22) of the SLC4A4 gene. This alteration results from a C to T substitution at nucleotide position 3091, causing the arginine (R) at amino acid position 1031 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV003481422 | SCV004226989 | uncertain significance | not provided | 2023-01-12 | criteria provided, single submitter | clinical testing | PP2 |
Fulgent Genetics, |
RCV005036600 | SCV005665576 | uncertain significance | Autosomal recessive proximal renal tubular acidosis | 2024-02-02 | criteria provided, single submitter | clinical testing |